相似文献
1
Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.
J Clin Microbiol. 2006 Feb;44(2):350-2. doi: 10.1128/JCM.44.2.350-352.2006.
2
Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis.
Indian J Exp Biol. 2009 Jun;47(6):454-62.
3
Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates.
J Clin Microbiol. 2006 Jul;44(7):2338-42. doi: 10.1128/JCM.00425-06.
4
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
J Clin Microbiol. 2006 Jul;44(7):2485-91. doi: 10.1128/JCM.00083-06.
5
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
J Clin Microbiol. 2005 Aug;43(8):3699-703. doi: 10.1128/JCM.43.8.3699-3703.2005.
6
7
Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
J Clin Microbiol. 2007 Aug;45(8):2635-40. doi: 10.1128/JCM.00521-07. Epub 2007 May 30.
8
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.
J Clin Microbiol. 2005 Sep;43(9):4880-4. doi: 10.1128/JCM.43.9.4880-4884.2005.
9
Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
New Microbiol. 2004 Jul;27(3):221-7.
10
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.
J Clin Microbiol. 2006 Oct;44(10):3659-64. doi: 10.1128/JCM.01054-06.
引用本文的文献
1
New insight in molecular detection of Mycobacterium tuberculosis.
AMB Express. 2024 Jun 21;14(1):74. doi: 10.1186/s13568-024-01730-3.
2
Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant Isolated from Healthcare Facilities in Mthatha.
Pathogens. 2023 Jul 5;12(7):909. doi: 10.3390/pathogens12070909.
3
Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis.
Infect Drug Resist. 2022 Aug 29;15:4971-4984. doi: 10.2147/IDR.S381643. eCollection 2022.
4
Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes.
Microb Genom. 2021 Dec;7(12). doi: 10.1099/mgen.0.000740.
5
Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola.
BMC Infect Dis. 2021 Oct 12;21(1):1056. doi: 10.1186/s12879-021-06763-8.
6
Rifampicin Mono-Resistant Tuberculosis-A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control.
Open Forum Infect Dis. 2021 Jan 28;8(2):ofab018. doi: 10.1093/ofid/ofab018. eCollection 2021 Feb.
7
High-resolution melt curve analysis for rapid detection of rifampicin resistance in : a single-centre study in Iran.
New Microbes New Infect. 2020 Mar 12;35:100665. doi: 10.1016/j.nmni.2020.100665. eCollection 2020 May.
8
Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in clinical isolates.
J Clin Tuberc Other Mycobact Dis. 2017 Jun 20;8:19-25. doi: 10.1016/j.jctube.2017.06.001. eCollection 2017 Aug.
9
Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review.
Front Microbiol. 2019 Apr 16;10:794. doi: 10.3389/fmicb.2019.00794. eCollection 2019.
10
Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.
PLoS One. 2019 Feb 7;14(2):e0212064. doi: 10.1371/journal.pone.0212064. eCollection 2019.
本文引用的文献
1
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
J Clin Microbiol. 2005 Aug;43(8):3699-703. doi: 10.1128/JCM.43.8.3699-3703.2005.
2
Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.
Antimicrob Agents Chemother. 2004 Sep;48(9):3373-81. doi: 10.1128/AAC.48.9.3373-3381.2004.
3
Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
Tuberculosis (Edinb). 2004;84(5):311-6. doi: 10.1016/j.tube.2003.12.001.
4
Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.
J Clin Microbiol. 2004 Jun;42(6):2425-31. doi: 10.1128/JCM.42.6.2425-2431.2004.
5
Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.
Int J Antimicrob Agents. 2004 May;23(5):473-9. doi: 10.1016/j.ijantimicag.2003.10.004.
6
WHO identifies drug-resistant tuberculosis "hotspots". Former Russian states are worst affected, but lack of data from China hides true extent of disease.
Lancet. 2004 Mar 20;363(9413):951. doi: 10.1016/s0140-6736(04)15823-6.
7
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.
Antimicrob Agents Chemother. 2003 Jun;47(6):2009-11. doi: 10.1128/AAC.47.6.2009-2011.2003.
8
The global situation of MDR-TB.
Tuberculosis (Edinb). 2003;83(1-3):44-51. doi: 10.1016/s1472-9792(02)00058-6.
9
Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens.
Scand J Infect Dis. 1999;31(3):269-73. doi: 10.1080/00365549950163563.
10
A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.
Antimicrob Agents Chemother. 1998 Sep;42(9):2443-5. doi: 10.1128/AAC.42.9.2443.
Zotero 插件